Palisade Bio (PALI) Retained Earnings (2010 - 2026)

Palisade Bio (PALI) has reported Retained Earnings for 17 consecutive years, with $288.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Retained Earnings rose 308.44% year-over-year to $288.0 million; the TTM figure through Mar 2026 stood at $288.0 million (up 308.44% YoY), while the FY2025 annual figure was $280.5 million, up 95.6% from the prior year.
• Retained Earnings improved to $288.0 million in Q1 2026 per PALI's latest filing, from $280.5 million in the prior quarter.
• Across five years, Retained Earnings topped out at $288.0 million in Q1 2026 and bottomed at -$143.8 million in Q3 2025.
• Historically, Retained Earnings has averaged $26.5 million across 5 years, with a median of $105.2 million in 2022.
• Annual changes were most pronounced in 2022 — Retained Earnings sank 3560670.89% — and 2026, when it jumped 308.44%.
• Palisade Bio's Retained Earnings stood at -$109.2 million in 2022, then slipped by 11.28% to -$121.5 million in 2023, then surged by 218.02% to $143.4 million in 2024, then soared by 95.6% to $280.5 million in 2025, then climbed by 2.67% to $288.0 million in 2026.
• Business Quant data shows PALI's Retained Earnings at $288.0 million in Q1 2026, $280.5 million in Q4 2025, and -$143.8 million in Q3 2025.